Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
Название протокола
Клинические исследование Chronic Lymphocytic Leukemia: Acalabrutinib, Venetoclax, Chemoimmunotherapy, Obinutuzumab - Реестр клинических исследований
